Our mission is to eliminate the organ transplant list. Orgavalue establishes a unique method to bioengineer personalized human organs, a market opportunity of €120 billion. Despite progress in medical therapies, the WHO estimates that only 10% of the worldwide need for organ transplantation is being met. In EU, 40 people die each day in the waiting list. Until 2050, the aged people above 55 - the risk group for need for an organ, will be around 42% in Europe. We expect to reach the market in 2028, in a B2B (hospitals), between Portugal and Spanish market.